X0206 3 2021-05-13 0 0001831828 Vera Therapeutics, Inc. VERA 0001778307 Cheng Andrew C/O VERA THERAPEUTICS, INC. 170 HARBOR WAY, 3RD FLOOR SOUTH SAN FRANCISCO CA 94080 1 0 0 0 Series C Preferred Stock Class A Common Stock 17488 I See footnote Stock Option (right to buy) 4.4031 2027-08-15 Class A Common Stock 3452 D Stock Option (right to buy) 2.3174 2030-01-15 Class A Common Stock 4315 D Stock Option (right to buy) 2.8968 2030-12-15 Class A Common Stock 61276 D The Series C Preferred Stock is convertible into Class A Common Stock on a 11.5869:1 basis (on an adjusted basis, after giving effect to the reverse stock split of the Class A Common Stock effected by the Issuer on May 7, 2021) and has no expiration date. Upon filing of the Issuer's Restated Certificate of Incorporation in connection with the Issuer's initial public offering, all shares of Series C Preferred Stock will be converted into shares of Class A Common Stock of the Issuer. The shares are held of record by Andrew K. Cheng, as Trustee of the Andrew Cheng 2010 Trust UA 10-26-2010. 1/48 of the shares subject to the option vested on July 8, 2017, and 1/48 of the shares vest monthly thereafter. 1/36 of the shares subject to the option vested on February 10, 2020, and 1/36 of the shares vest monthly thereafter. 1/36 of the shares subject to the option vested on January 16, 2021, and 1/36 of the shares vest monthly thereafter. /s/ Joseph R. Young, Attorney-in-Fact 2021-05-13